Science

Bahar Saberzadeh Ardestani: How spatial protein profiles in d-MMR colorectal cancer predict response to anti-PD-1 therapy

Bahar Saberzadeh Ardestani/medicine.yale.edu

Feb 28, 2025, 08:35

Bahar Saberzadeh Ardestani: How spatial protein profiles in d-MMR colorectal cancer predict response to anti-PD-1 therapy

Bahar Saberzadeh Ardestani, Research fellow at Mayo Clinic Gastroenterology & Hepatology, shared an article on X:

“Excited to share our work in Clinical Cancer Research revealing how spatial protein profiles in d-MMR colorectal cancer micro environments predict response to anti-PD-1 therapy!”

Spatially resolved, multi-region proteomics for prediction of immunotherapy outcome in deficient mismatch repair metastatic colorectal cancer.

Authors: Bahar Saberzadeh-Ardestani, et al.

anti-PD-1 therapy Bahar Saberzadeh Ardestani cancer Clinical Cancer Research colorectal cancer fight against cancer Gastroenterology Global fight against cancer Hepatology immunotherapy Mayo Clinic OncoDaily Oncology

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding